Latest headlines
Merck News
The latest Merck (MRK) news, aggregated as it breaks. News moves sentiment and sentiment moves price, so read these MRK headlines next to the live Merck Fear and Greed Index.
Latest Merck Headlines46
These New Drugs Could Fuel Fresh Highs for Biotech and Pharma Stocks
barrons.com · Aug 7, 2026
Merck (MRK) Is Considered a Good Investment by Brokers: Is That True?
zacks.com · Aug 6, 2026
U.S. FDA Accepts sBLA for ENFLONSIA™ (clesrovimab-cfor) to Update its Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease Indication to Include Children Under Two Years at Increased Risk for Severe RSV for Their Second Season
businesswire.com · Aug 6, 2026
MRK Q2 Earnings Call Puts Pipeline Progress in Focus
zacks.com · Aug 5, 2026
Merck & Co., Inc. Q2 Earnings Call Highlights
marketbeat.com · Aug 5, 2026
Merck & Co Inc (MRK) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and Strategic Pipeline Advances Amid One-Time Charges
gurufocus.com · Aug 4, 2026
MRK Q2 Earnings & Sales Beat Estimates, '26 Sales View Raised
zacks.com · Aug 4, 2026
Merck & Co., Inc. (MRK) Q2 2026 Earnings Call Transcript
seekingalpha.com · Aug 4, 2026
Compared to Estimates, Merck (MRK) Q2 Earnings: A Look at Key Metrics
zacks.com · Aug 4, 2026
Stock Futures Surge on Strait of Hormuz Optimism
schaeffersresearch.com · Aug 4, 2026
Merck (MRK) Reports Q2 Loss, Beats Revenue Estimates
zacks.com · Aug 4, 2026
Merck Cuts Full-Year Profit Forecast as Acquisition Costs Weigh on Bottom Line
wsj.com · Aug 4, 2026
Merck posts better-than-expected second-quarter results on Keytruda strength
reuters.com · Aug 4, 2026
Merck hikes revenue outlook as new drug sales grow, but cuts profit guidance due to deal charges
cnbc.com · Aug 4, 2026
Merck Delivers a Clean Earnings Beat on Oncology Strength. Is It Enough to Impress Wall Street?
barrons.com · Aug 4, 2026
Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2026 Financial Results; Highlights Key Regulatory and Clinical Milestones Across Broad, Diverse Pipeline
businesswire.com · Aug 4, 2026
Merck & Co., Inc. (MRK) Discusses HIV Program Updates and Phase III Data from International AIDS Conference Transcript
seekingalpha.com · Aug 3, 2026
Merck Spotlights Weekly HIV Treatment, Monthly PrEP as $5B Growth Opportunity
marketbeat.com · Aug 3, 2026
Merck: Heading Into Q2 Earnings, The Keytruda Cliff Looks Increasingly Less Steep
seekingalpha.com · Jul 31, 2026
Should You Buy, Sell or Hold Merck Stock Ahead of Q2 Earnings?
zacks.com · Jul 30, 2026
Exploring Analyst Estimates for Merck (MRK) Q2 Earnings, Beyond Revenue and EPS
zacks.com · Jul 30, 2026
Merck, Wellcome partner with global health group to make Ebola vaccine for clinical trials
reuters.com · Jul 30, 2026
Merck Announces Fourth-Quarter 2026 Dividend
gurufocus.com · Jul 29, 2026
Merck Announces Fourth-Quarter 2026 Dividend
businesswire.com · Jul 29, 2026
Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock
zacks.com · Jul 29, 2026
Earnings Preview: Merck (MRK) Q2 Earnings Expected to Decline
zacks.com · Jul 28, 2026
Merck licenses experimental HIV pill to generic makers in 129 countries
reuters.com · Jul 24, 2026
Merck Announces Initial Access Plans for Alimatravir, an Investigational Once-Monthly Oral HIV Pre-Exposure Prophylaxis in Phase 3 Development
businesswire.com · Jul 24, 2026
Tessera Therapeutics Appoints Joseph Romanelli as President and Chief Executive Officer
prnewswire.com · Jul 23, 2026
Will Keytruda Remain the Driving Force Behind Merck's Q2 Performance?
zacks.com · Jul 22, 2026
Gilead, Merck weekly HIV pill keeps virus suppressed in late-stage trials
reuters.com · Jul 21, 2026
Is It Worth Investing in Merck (MRK) Based on Wall Street's Bullish Views?
zacks.com · Jul 21, 2026
Investigational Once-Weekly Oral HIV Treatment Regimen of Islatravir and Lenacapavir Maintained Virological Suppression in Adults With HIV Who Switched Antiretroviral Therapy
businesswire.com · Jul 21, 2026
Merck (MRK) Declines More Than Market: Some Information for Investors
zacks.com · Jul 20, 2026
Merck Just Won The Race For The First Cholesterol Pill: What It Means For Your Heart And Your Portfolio
benzinga.com · Jul 20, 2026
For Global Pharma Exposure Is the VanEck Pharmaceutical ETF or iShares Healthcare Fund the Better Buy in 2026?
fool.com · Jul 20, 2026
What Comes After Merck's Keytruda? The Race for the Next Standard Cancer Treatment.
barrons.com · Jul 20, 2026
Merck: 'Strong Buy' Lipfendra FDA First And Continued Oncology Expansions
seekingalpha.com · Jul 17, 2026
MRK Stock Jumps on FDA Nod for Cholesterol-Lowering Pill
zacks.com · Jul 17, 2026
Compass Pathways gains Jefferies support as COMP360 data distinguishes psychological support from psychotherapy
proactiveinvestors.com · Jul 17, 2026
Use These ETFs as Health Stocks LLY, UNH, MRK Thrive
etftrends.com · Jul 17, 2026
New Cholesterol Pill, Earnings Growth Boost Merck Shares
fxempire.com · Jul 17, 2026
FDA Approval Adds New Cholesterol Treatment Option in Merck Portfolio
benzinga.com · Jul 16, 2026
FDA signs off on Merck's cholesterol-lowering pill — the first oral treatment of its kind
nypost.com · Jul 16, 2026
Nasdaq slides as chip selloff drags Wall Street lower
proactiveinvestors.com · Jul 16, 2026
Nasdaq dragged by chip sell-off, Abbott, UnitedHealth lead risers
proactiveinvestors.com · Jul 16, 2026
Why Is Merck Up or Down Today?
When Merck (MRK) moves sharply, the reason is almost always in the headlines above. Earnings, guidance, analyst upgrades and downgrades, product news and macro data are the usual drivers of a MRK move on the day. The feed shows what broke and when, and the sentiment tag on each story shows whether the coverage skews positive or negative, so you can see at a glance why Merck is up or down today.
How Merck News Affects the Price
News does not move the Merck (MRK) price directly, it moves sentiment, and sentiment moves price. A run of negative headlines pulls the Merck Fear and Greed Index toward fear, while positive coverage pushes it toward greed, often before the price has fully reacted. A surprise story usually shows up first as a spike in Merck trading volume. That is the chain to watch: headline, sentiment, volume, then the MRK price.
Trade the Merck News With Sentiment
Headlines tell you what happened; the Fear and Greed Index tells you how the crowd is reacting. Watch Merck trading volume spike on a big story, check the Merck price history for context, follow the live MRK price, see the Merck price prediction, and read the Merck Fear and Greed Index for mood.
How do you feel about Merck?
1DFrequently asked questions
Why is Merck up or down today?
What is the latest Merck news?
Where does Merck news come from?
How often is Merck news updated?
How does Merck news relate to its Fear and Greed Index?
Headlines are aggregated from third-party sources and link to the original publishers. CFGI does not author or endorse them.
About CFGI
The per-asset sentiment record.
CFGI is a market sentiment data company that scores crowd emotion from 0 to 100 across crypto and stock markets. Crypto readings cover the whole market and hundreds of individual assets across 15-minute, 1-hour, 4-hour and daily views. The stock index gives a live daily reading for wider stock market sentiment.
Every CFGI score is built from 10 indicators: price, volatility, volume, impulse, technical analysis, social media, dominance, search interest, whale movements and order book pressure. The same data powers our API, alerts and embeddable widgets.